How would you treat a patient with oligometastatic disease to the lung for whom SBRT/SABR is not feasible?  

How would you approach treatment if SBRT was not technically possible?

How would you opt to treat if SBRT was instead not covered by insurance, and would this be different than your approach above? 



Answer from: Radiation Oncologist at Community Practice